Lipigon Pharmaceuticals AB (LPGO) — Cash Flow Reinvestment Rate
Latest as of December 2024:
0.00x
Lipigon Pharmaceuticals AB (LPGO) has a Cash Flow Reinvestment Rate of 0.00x as of December 2024, reinvesting Skr0.00 (capex Skr0.00 ) from operating cash flow of Skr1.06 Million. Explore Lipigon Pharmaceuticals AB capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
Skr0.00
Capex + Investments
Operating Cash Flow
Skr1.06 Million
SEK
Capital Expenditures
Skr0.00
SEK
Annual Cash Flow Reinvestment Rate for Lipigon Pharmaceuticals AB (None–None)
Year-by-year capital reinvestment analysis for Lipigon Pharmaceuticals AB. For live market cap and broader valuation context, see Lipigon Pharmaceuticals AB market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow